These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9737834)
61. [Rehabilitation of patients with chronic purulent otitis media]. Enin IP Vestn Otorinolaringol; 1999; (2):5-7. PubMed ID: 10226482 [TBL] [Abstract][Full Text] [Related]
62. [Correlation between histomorphometric changes and the type of aerobic bacteria isolated in chronic suppurative otitis media]. Zivković-Marinkov E; Stanković M; Mihailović D; Bojanović M Vojnosanit Pregl; 2011 Jan; 68(1):46-50. PubMed ID: 21425618 [TBL] [Abstract][Full Text] [Related]
63. Treatment of chronic suppurative otitis media with topical tobramycin and dexamethasone. Alper CM; Dohar JE; Gulhan M; Ozunlu A; Bagger-Sjobak D; Hebda PA; Swarts JD Arch Otolaryngol Head Neck Surg; 2000 Feb; 126(2):165-73. PubMed ID: 10680867 [TBL] [Abstract][Full Text] [Related]
64. Ototopical drops containing a novel antibacterial synthetic peptide: Safety and efficacy in adults with chronic suppurative otitis media. Peek NFAW; Nell MJ; Brand R; Jansen-Werkhoven T; van Hoogdalem EJ; Verrijk R; Vonk MJ; Wafelman AR; Valentijn ARPM; Frijns JHM; Hiemstra PS; Drijfhout JW; Nibbering PH; Grote JJ PLoS One; 2020; 15(4):e0231573. PubMed ID: 32287316 [TBL] [Abstract][Full Text] [Related]
65. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media. Arguedas A; Dagan R; Pichichero M; Leibovitz E; Blumer J; McNeeley DF; Melkote R; Noel GJ Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154 [TBL] [Abstract][Full Text] [Related]
66. Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children. Sher L; Arguedas A; Husseman M; Pichichero M; Hamed KA; Biswas D; Pierce P; Echols R Pediatr Infect Dis J; 2005 Apr; 24(4):301-8. PubMed ID: 15818288 [TBL] [Abstract][Full Text] [Related]
67. Bacteriology of chronic suppurative otitis media--a multicenter study. Yeo SG; Park DC; Hong SM; Cha CI; Kim MG Acta Otolaryngol; 2007 Oct; 127(10):1062-7. PubMed ID: 17851935 [TBL] [Abstract][Full Text] [Related]
68. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults. Sydnor TA; Kopp EJ; Anthony KE; LoCoco JM; Kim SS; Fowler CL Ann Allergy Asthma Immunol; 1998 Apr; 80(4):357-62. PubMed ID: 9564988 [TBL] [Abstract][Full Text] [Related]
69. Randomised controlled trial of treatment of chronic suppurative otitis media in Kenyan schoolchildren. Smith AW; Hatcher J; Mackenzie IJ; Thompson S; Bal I; Macharia I; Mugwe P; Okoth-Olende C; Oburra H; Wanjohi Z Lancet; 1996 Oct; 348(9035):1128-33. PubMed ID: 8888166 [TBL] [Abstract][Full Text] [Related]
70. Treatment with a neutrophil elastase inhibitor and ofloxacin reduces P. aeruginosa burden in a mouse model of chronic suppurative otitis media. Khomtchouk KM; Joseph LI; Khomtchouk BB; Kouhi A; Massa S; Xia A; Koliesnik I; Pletzer D; Bollyky PL; Santa Maria PL NPJ Biofilms Microbiomes; 2021 Apr; 7(1):31. PubMed ID: 33824337 [TBL] [Abstract][Full Text] [Related]
71. Topical Therapy Failure in Chronic Suppurative Otitis Media is Due to Persister Cells in Biofilms. Santa Maria PL; Kaufman AC; Bacacao B; Thai A; Chen X; Xia A; Cao Z; Fouad A; Bekale LA Otol Neurotol; 2021 Oct; 42(9):e1263-e1272. PubMed ID: 34149028 [TBL] [Abstract][Full Text] [Related]
72. In vitro efficacy of the successive or staggered use of eardrops. Kalcioglu MT; Ozturan O; Durmaz R; Aktas E Eur Arch Otorhinolaryngol; 2006 May; 263(5):395-8. PubMed ID: 16328405 [TBL] [Abstract][Full Text] [Related]
73. Preoperative, intraoperative, and postoperative results of bacterial culture from patients with chronic suppurative otitis media. Ahn JH; Kim MN; Suk YA; Moon BJ Otol Neurotol; 2012 Jan; 33(1):54-9. PubMed ID: 22143302 [TBL] [Abstract][Full Text] [Related]
74. [Clinical efficacy of ciprofloxacin and ofloxacin]. Jiang SC; Wang XF; Miao JZ Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):444-8. PubMed ID: 7867437 [TBL] [Abstract][Full Text] [Related]
75. Susceptibility of microorganisms isolated from chronic suppurative otitis media to ciprofloxacin. Altuntas A; Aslan A; Eren N; Unal A; Nalca Y Eur Arch Otorhinolaryngol; 1996; 253(6):364-6. PubMed ID: 8858262 [TBL] [Abstract][Full Text] [Related]
76. Vinegar treatment in the management of granular myringitis. Jung HH; Cho SD; Yoo CK; Lim HH; Chae SW J Laryngol Otol; 2002 Mar; 116(3):176-80. PubMed ID: 11893257 [TBL] [Abstract][Full Text] [Related]
77. Role of glucocorticoids in ototopical antibiotic-steroid preparations in the treatment of chronic suppurative otitis media. Indudharan R; Valuyeetham KA; Raju SS Arch Med Res; 2005; 36(2):154-8. PubMed ID: 15847949 [TBL] [Abstract][Full Text] [Related]
78. Recurrent otorrhea in chronic suppurative otitis media: is biofilm the missing link? Jensen RG; Johansen HK; Bjarnsholt T; Eickhardt-Sørensen SR; Homøe P Eur Arch Otorhinolaryngol; 2017 Jul; 274(7):2741-2747. PubMed ID: 28466356 [TBL] [Abstract][Full Text] [Related]
79. Microbiology and drug sensitivity patterns of chronic suppurative otitis media. Aslam MA; Ahmed Z; Azim R J Coll Physicians Surg Pak; 2004 Aug; 14(8):459-61. PubMed ID: 15321034 [TBL] [Abstract][Full Text] [Related]
80. Microbiology of otorrhea in children with tympanostomy tubes: implications for therapy. Dohar J Int J Pediatr Otorhinolaryngol; 2003 Dec; 67(12):1317-23. PubMed ID: 14643475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]